Publicaciones en las que colabora con Fernando Civeira Murillo (7)

2024

  1. PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention

    Lipids in Health and Disease , Vol. 23, Núm. 1

2023

  1. Impact of conducting a genetic study on the management of familial hypercholesterolemia; A retrospective cohort study of 4854 patients from the SEA Dyslipidemia Registry

    Journal of Clinical Lipidology, Vol. 17, Núm. 6, pp. 717-731

2022

  1. Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial

    BMC Cardiovascular Disorders, Vol. 22, Núm. 1

2020

  1. Documento de consenso de un grupo de expertos de la Sociedad Española de Arteriosclerosis (SEA) sobre el uso clínico de la resonancia magnética nuclear en el estudio del metabolismo lipoproteico (Liposcale)

    Clínica e investigación en arteriosclerosis, Vol. 32, Núm. 5, pp. 219-229

2016

  1. Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

    Journal of the American Heart Association, Vol. 5, Núm. 9

2005

  1. Screening of APOB gene mutations in subjects with clinical diagnosis of familial hypercholesterolemia

    Human Biology, Vol. 77, Núm. 5, pp. 663-673

2002

  1. Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases

    Medicina Clinica, Vol. 118, Núm. 13, pp. 487-492